Abbott Laboratories (ABT) Raw Materials (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Raw Materials data on file, last reported at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials rose 2.08% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 2.08% YoY), and the FY2025 full-year result was $1.6 billion, down 2.78% from the prior year.
• Raw Materials climbed to $1.7 billion in Q1 2026, from $1.6 billion in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.0 billion in Q2 2023 to a low of $1.5 billion in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2022 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials increased 26.08% in 2023 and declined 10.73% in 2025, its largest moves.
• Tracing ABT's Raw Materials over 5 years: stood at $1.7 billion in 2022, then advanced by 7.64% to $1.8 billion in 2023, then decreased by 8.97% to $1.7 billion in 2024, then slipped by 2.78% to $1.6 billion in 2025, then grew by 7.03% to $1.7 billion in 2026.
• Business Quant data shows ABT's Raw Materials at $1.7 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.